Oophorectomy, estrogen, and dementia: A 2014 update

Molecular and Cellular Endocrinology

Volumn 389, Issue 1-2, 2014, Pages 7-12

  Rocca, Walter A ^a,b   Grossardt, Brandon R ^a   Shuster, Lynne T ^b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cognitive impairment; Dementia; Estrogen; Menopause; Oophorectomy; Timing hypothesis

Indexed keywords

ESTROGEN; GESTAGEN; NEUROPROTECTIVE AGENT;

AGING; ALZHEIMER DISEASE; CAUSAL ATTRIBUTION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; EARLY MENOPAUSE; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; MEDICAL TERMINOLOGY; MENOPAUSAL SYNDROME; MENOPAUSE; NEUROPROTECTION; OVARIECTOMY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; AGE; CASE CONTROL STUDY; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; DRUG EFFECTS; FEMALE; METABOLISM; OBSERVATIONAL STUDY; PROCEDURES; RISK; WOMEN'S HEALTH;

AGE FACTORS; CASE-CONTROL STUDIES; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; DEMENTIA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; NEUROPROTECTIVE AGENTS; OBSERVATIONAL STUDY AS TOPIC; OVARIECTOMY; RISK; WOMEN'S HEALTH;

EID: 84901483236     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.01.020     Document Type: Review

References (52)

1. Armstrong K., Schwartz J.S., Randall T., Rubin S.C., Weber B. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. J. Clin. Oncol. 2004, 22:1045-1054.
2. Bove R., Secor E., Chibnik L.B., Barnes L.L., Schneider J.A., Bennett D.A., De Jager P.L. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 2014, 82:222-229.
3. Brinton R.D. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci. 2008, 31:529-537.
4. Buist D.S., Newton K.M., Miglioretti D.L., Beverly K., Connelly M.T., Andrade S., Hartsfield C.L., Wei F., Chan K.A., Kessler L. Hormone therapy prescribing patterns in the United States. Obstet Gynecol. 2004, 104:1042-1050.
5. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., Hsia J., Margolis K.L., Hogan P.E., Wallace R., Dailey M., Freeman R., Hays J. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291:2959-2968.
6. Farquhar C.M., Sadler L., Harvey S.A., Stewart A.W. The association of hysterectomy and menopause: a prospective cohort study. Int. J. Obstet. Gynaecol. 2005, 112:956-962.
7. Farrag A.K., Khedr E.M., Abdel-Aleem H., Rageh T.A. Effect of surgical menopause on cognitive functions. Dement Geriatr. Cogn. Disord. 2002, 13:193-198.
8. Haas J.S., Kaplan C.P., Gerstenberger E.P., Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann. Intern. Med. 2004, 140:184-188.
9. Henderson V.W., Brinton R.D. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog. Brain Res. 2010, 182:77-96.
10. Henderson V.W., Rocca W.A. Estrogens and Alzheimer disease risk: is there a window of opportunity?. Neurology 2012, 79:1840-1841.
11. Henderson V.W., Sherwin B.B. Surgical versus natural menopause: cognitive issues. Menopause 2007, 14:572-579.
12. Henderson V.W., Benke K.S., Green R.C., Cupples L.A., Farrer L.A. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J. Neurol. Neurosurg. Psychiatry. 2005, 76:103-105.
13. Hersh A.L., Stefanick M.L., Stafford R.S. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004, 291:47-53.
14. Hogervorst E., Bandelow S. Should surgical menopausal women be treated with estrogens to decrease the risk of dementia?. Neurology 2007, 69:1070-1071.
15. Hogervorst E., Williams J., Budge M., Riedel W., Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000, 101:485-512.
16. Kok H.S., Kuh D., Cooper R., van der Schouw Y.T., Grobbee D.E., Wadsworth M.E., Richards M. Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause 2006, 13:19-27.
17. Kritz-Silverstein D., Barrett-Connor E. Hysterectomy, oophorectomy, and cognitive function in older women. J. Am. Geriatr. Soc. 2002, 50:55-61.
18. LeBlanc E.S., Janowsky J., Chan B.K., Nelson H.D. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001, 285:1489-1499.
19. Lethaby A., Hogervorst E., Richards M., Yesufu A., Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst. Rev. 2008, CD003122.
20. Manson J.E., Bassuk S.S., Harman S.M., Brinton E.A., Cedars M.I., Lobo R., Merriam G.R., Miller V.M., Naftolin F., Santoro N. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 2006, 13:139-147.
21. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl. J. Med. 1999, 340:1801-1811.
22. Mendelsohn M.E., Karas R.H. Molecular and cellular basis of cardiovascular gender differences. Science 2005, 308:1583-1587.
23. Mendelsohn M.E., Karas R.H. HRT and the young at heart. N Engl. J. Med. 2007, 356:2639-2641.
24. Morrison J.H., Brinton R.D., Schmidt P.J., Gore A.C. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J. Neurosci. 2006, 26:10332-10348.
25. Nappi R.E., Sinforiani E., Mauri M., Bono G., Polatti F., Nappi G. Memory functioning at menopause: impact of age in ovariectomized women. Gynecol. Obstet. Invest. 1999, 47:29-36.
26. Parker W.H., Jacoby V., Shoupe D., Rocca W. Effect of bilateral oophorectomy on women's long-term health. Womens Health (Lond Engl). 2009, 5:565-576.
27. Petitti D.B., Crooks V.C., Chiu V., Buckwalter J.G., Chui H.C. Incidence of dementia in long-term hormone users. Am. J. Epidemiol. 2008, 167:692-700.
28. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992, 17:485-495.
29. Phung T.K., Waltoft B.L., Laursen T.M., Settnes A., Kessing L.V., Mortensen P.B., Waldemar G. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement Geriatr. Cogn. Disord. 2010, 30:43-50.
30. Porta M.S., International Epidemiological Association A Dictionary of Epidemiology 2008, Oxford University Press, Oxford; New York, Vol.
31. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., Gass M.L., Stefanick M.L., Lane D.S., Hays J., Johnson K.C., Coker L.H., Dailey M., Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289:2663-2672.
32. Roberts R.O., Cha R.H., Knopman D.S., Petersen R.C., Rocca W.A. Postmenopausal estrogen therapy and Alzheimer disease: overall negative findings. Alzheimer Dis. Assoc. Disord. 2006, 20:141-146.
33. Rocca W.A., Henderson V.W. Is there a link between gynecologic surgeries and Alzheimer disease?. Neurology 2014, 82:196-197.
34. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., Melton L.J. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007, 69:1074-1083.
35. Rocca W.A., Grossardt B.R., Maraganore D.M. The long-term effects of oophorectomy on cognitive and motor aging are age dependent. Neurodegener Dis. 2008, 5:257-260.
36. Rocca W.A., Shuster L.T., Grossardt B.R., Maraganore D.M., Gostout B.S., Geda Y.E., Melton L.J. Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Womens Health (Lond Engl). 2009, 5:39-48.
37. Rocca W.A., Grossardt B.R., Shuster L.T. Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener Dis. 2010, 7:163-166.
38. Rocca W.A., Grossardt B.R., Shuster L.T. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res. 2011, 1379:188-198.
39. Shao H., Breitner J.C., Whitmer R.A., Wang J., Hayden K., Wengreen H., Corcoran C., Tschanz J., Norton M., Munger R., Welsh-Bohmer K., Zandi P.P. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology 2012, 79:1846-1852.
40. Sherwin B.B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988, 13:345-357.
41. Sherwin B.B., Phillips S.J. Estrogen and cognitive functioning in surgically menopausal women. Ann. N Y Acad. Sci. 1990, 592:474-475.
42. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289:2651-2662.
43. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., Fillit H., Stefanick M.L., Hendrix S.L., Lewis C.E., Masaki K., Coker L.H. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291:2947-2958.
44. Shuster L.T., Rhodes D.J., Gostout B.S., Grossardt B.R., Rocca W.A. Premature menopause or early menopause: long-term health consequences. Maturitas 2010, 65:161-166.
45. Siegfried T. Neuroscience: it's all in the timing. Nature 2007, 445:359-361.
46. Szklo M., Nieto F.J. Epidemiology: Beyond the Basics 2007, Jones and Bartlett Publishers, Sudbury, Vol.
47. Utian W.H. Semantics, menopause-related terminology, and the STRAW reproductive aging staging system. Menopause 2001, 8:398-401.
48. Vujovic S., Brincat M., Erel T., Gambacciani M., Lambrinoudaki I., Moen M.H., Schenck-Gustafsson K., Tremollieres F., Rozenberg S., Rees M. EMAS position statement: managing women with premature ovarian failure. Maturitas 2010, 67:91-93.
49. Whitmer R.A., Quesenberry C.P., Zhou J., Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann. Neurol. 2011, 69:163-169.
50. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998, 279:688-695.
51. Zhang Q.G., Han D., Wang R.M., Dong Y., Yang F., Vadlamudi R.K., Brann D.W. C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection. Proc. Nat. Acad. Sci. USA 2011, 108. E617-24.
52. Zhou G., Liu J., Sun F., Duan L., Yan B., Peng Q. Cognitive functioning in elderly women who underwent unilateral oophorectomy before menopause. Int. J. Neurosci. 2011, 121:196-200.